Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Mulattieri
Pegylated Liposomal Doxorubicin in the Treatment of Primary Cutaneous T-Cell Lymphomas
Haematologica
Hematology
Related publications
Gemcitabine Plus Liposomal Doxorubicin for Relapsed Refractory T-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
An Overview of Cutaneous T Cell Lymphomas
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Primary Cutaneous Acral CD8+ T-Cell Lymphomas Relapse More Frequently in Younger Patients
British Journal of Haematology
Hematology
Emerging Pharmacotherapies in Ovarian Cancer: Focus on Pegylated Liposomal Doxorubicin
Clinical Medicine Reviews in Women's Health
Vorinostat Approved in Japan for Treatment of Cutaneous T-Cell Lymphomas: Status and Prospects
OncoTargets and Therapy
Oncology
Pharmacology
Efficacy and Safety of Non-Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer Therapy
OnCOReview
Oncology
Pegylated Liposomal Doxorubicin Combined With Cyclophosphamide, Vincristine/Vindesine, and Prednisone in Patients With Aggressive T-Cell Lymphoma: Preliminary Results of Aphase Ii Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Japanese Guidelines for Cutaneous Lymphomas: Cutaneous Adult T Cell Leukemia/Lymphoma (ATLL)
Skin Cancer
Modeling Pegylated Liposomal Doxorubicin-Induced Hand-Foot Syndrome and Intestinal Mucositis in Zebrafish
OncoTargets and Therapy
Oncology
Pharmacology
